Product Details:
- Product Name: Isofraxidin
- CAS Number: 486-21-5
- Purity: ≥98% HPLC
- Molecular Formula: C11H10O4
- Molecular Weight: 206.20 g/mol
- Appearance: Light yellow crystalline powder
- Solubility: Soluble in DMSO, ethanol, and slightly soluble in water
- Storage: Store at -20°C, protected from light and moisture
Features & Benefits:
- Antioxidant Activity: Offers protection against oxidative stress, contributing to cellular health and longevity.
- Anti-inflammatory Effects: Modulates inflammatory responses, potentially benefiting conditions such as arthritis and other inflammatory diseases.
- Antimicrobial Properties: Exhibits activity against a range of bacterial and fungal pathogens, supporting its use in infection control.
- Natural Origin: Derived from traditional medicinal plants, providing a holistic approach to health and wellness.
Applications:
- Pharmaceutical Research: Investigated for its potential in developing treatments for inflammation, oxidative stress-related diseases, and infections.
- Nutraceuticals: Utilized in dietary supplements for its health-promoting effects, especially in supporting immune function and reducing inflammation.
- Cosmetics: Incorporated into skincare products for its antioxidant and antimicrobial benefits, promoting skin health.
- Herbal Medicine: Used in traditional herbal formulations for its therapeutic properties.
Safety & Compliance:
- Manufactured under stringent quality control standards to ensure high purity and safety.
- Accompanied by a comprehensive Certificate of Analysis (CoA) for quality assurance.
- Recommended for use by healthcare professionals and researchers familiar with the handling and safety protocols of bioactive compounds.
Packaging:
- Available in 20mg and 1g quantities to support a range of research and development projects.
- Packaged in air-tight containers to maintain stability and ensure product integrity during storage and handling.
Details
CAS# | 482-45-1 |
---|---|
Purity | ≥98%HPLC |
Package | 20mg;1g |
Reviews
There are no reviews yet.